Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on PET/MRI in Switzerland
Total 0 results
Nothing found
Sponsors and Collaborators
Montreal Neurological Institute and Hospital
Jeffrey Rudolph
Kawin Technology Share-holding Co., Ltd.
Jeffrey W. Clark, MD
Honda R and D Americas, Inc.
The Third Hospital of Changsha
MingSight Pharmaceuticals Pty Limited
Wushan County People's Hospital
Marilia Medicine School
Northern California Melanoma Center
Rex Bionics Plc
Mitchell Scheiman
Health Parametrics Inc.
New York State Health Foundation
Ionis Pharmaceuticals
Zahra Rabbani Khah
John Granton
European Network For Smoking and Tobacco Prevention
CTC Bio, Inc.
Medtronic Atrial Fibrillation Solutions
View Full List
Medical Conditions
Postmenopausal Diabetes
Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma
Heart Defect, Congenital
Ketamine Treatment
Low Birthweight, Extremely (999 Grams or Less)
Nutritional Edema
Radial Artery Catheterization
Idiopathic Gastric Stasis
Periodontology
Myeloproliferative Disease
Pertussis Immunisation
Develop a New Survey Instrument to Measure Behavioural Determinants of Hand Washing and Water Treatment Like Disgust and Shame or Social Pressure.
Canthal Lines
Suspected Neonatal Encephalopathy
Acute Necrotizing Encephalopathy
Influenza and Other Novel Respiratory Viruses
Pediatric Anaplastic Large Cell Lymphoma
Fecal Elastase-1 Test
Improved Vocal Fold Status
Moderate to Severe Functional Impairments
View Full List
Drug Interventions
Postoperative analgesia management
Rifaximin
200 µg doxorubicin-containing MNA
Irinotecan, capecitabine, oxaliplatin (IXO) and bevacizumab
Levobupivacaine, clonidine
Nimotuzumab
Bendamustine
Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone/Prednisolone (CHOP)
5-Fluoro-3-Pyridinecarboxylic Acid
Levcromakalim
Toripalimab plus Anlotinib
Tenofovir disoproxil fumarate (TDF) 300mg co-formulated with emtricitabine (FTC 200mg) once daily oral administration
Ombrabulin (AVE8062)
Fludarabine
CKD-519
Pentostatin
Hydroxychloroquine
AZD7798
ESK981
Up-and-down method to find out effective concentration of remifentanil for preventing cough during emergence
View Full List
CROs by country
Contract Research Organizations in Austria
Contract Research Organizations in Belgium
Contract Research Organizations in Burkina Faso
Contract Research Organizations in Guatemala
Contract Research Organizations in Guinea
Contract Research Organizations in Japan
Contract Research Organizations in Kazakhstan
Contract Research Organizations in Mali
Contract Research Organizations in Saint Lucia
Contract Research Organizations in Senegal
Contract Research Organizations in Slovakia
Contract Research Organizations in Turkmenistan
Contract Research Organizations in Uzbekistan
CRO list by country
CROs in Belarus
X7 Research
ICON
OCT Clinical
Belnico
PSI
SGS
PRA Health Sciences
SanaClis
All CROs in Belarus
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe